Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - vankomycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

octapharma (ip) sprl, belgicko - normálne ľudské imunoglobulíny na intravenózne použitie - 59 - immunopraeparata

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sanquin plasma products b.v, holandsko - normálne ľudské imunoglobulíny na intravenózne použitie - 59 - immunopraeparata

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

gedeon richter plc., maďarsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - purpura, trombocytopenická, idiopatická - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 a 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 a 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

teva b.v. - kyselina zoledrónová - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - lieky na liečbu chorôb kostí - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. liečba paget je ochorenie kostí u dospelých.

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sanofi winthrop industrie, francúzsko - amiodarón - 13 - antiarrythmica

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

merz pharmaceuticals gmbh, nemecko - botulotoxín - 63 - myorelaxantia

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sol spa, taliansko - oxid dusný - 05 - anaesthetica (celkovÉ)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

merz pharmaceuticals gmbh, nemecko - botulotoxín - 63 - myorelaxantia